tiprankstipranks
Immuneering (IMRX)
NASDAQ:IMRX
US Market
Holding IMRX?
Track your performance easily

Immuneering (IMRX) Financial Statements

281 Followers

Immuneering Financial Overview

Immuneering's market cap is currently ―. The company's EPS TTM is $-1.966; its P/E ratio is -1.07; Immuneering is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $-0.46. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue--$ 19.20K--
Gross Profit--$ 19.20K--
EBIT$ -14.60M$ -14.08M$ -14.31M$ -16.30M$ -13.93M
EBITDA$ -14.42M$ -13.74M$ -14.28M$ -16.21M$ -13.84M
Net Income Common Stockholders$ -14.60M$ -14.08M$ -14.31M$ -15.08M$ -12.60M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 50.66M$ 59.73M$ 71.28M$ 85.67M$ 97.24M
Total Assets$ 68.56M$ 77.09M$ 87.98M$ 102.58M$ 113.88M
Total Debt$ 4.24M$ 4.31M$ 4.38M$ 4.46M$ 4.54M
Net Debt$ -46.42M$ -55.42M$ -66.90M$ -81.20M$ -92.70M
Total Liabilities$ 10.84M$ 10.78M$ 9.26M$ 12.01M$ 9.86M
Stockholders Equity$ 57.72M$ 66.31M$ 78.72M$ 90.58M$ 104.02M
Cash Flow-
Free Cash Flow$ -13.48M$ -11.56M$ -15.53M$ -11.95M$ -12.08M
Operating Cash Flow$ -13.47M$ -11.53M$ -15.49M$ -11.78M$ -12.03M
Investing Cash Flow$ -5.42M$ 4.97M$ 21.39M$ 3.13M$ -23.97M
Financing Cash Flow$ 4.36M-$ 979.92K$ 7.83K$ 21.45K
Currency in USD

Immuneering Earnings and Revenue History

Immuneering Debt to Assets

Immuneering Cash Flow

Immuneering Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis